A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT ID: NCT06764485
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
960 participants
INTERVENTIONAL
2025-03-13
2029-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06067841
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
NCT05169684
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
NCT03706365
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer
NCT00326586
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT00638690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Part 1, participants will be randomized 1:1:1 to one of the two BMS-986365 dose levels, or to the active comparator arm (investigator's choice). In Part 2 of the study, participants will be randomized 1:1 between BMS-986365 selected dose, or to the active comparator arm (investigator's choice).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Part 1: Dose 1
BMS-986365
Specified dose on specified days
Part 1: Dose 2
BMS-986365
Specified dose on specified days
Part 1: Comparator 1
Enzalutamide or Abiraterone Acetate + Prednisone/Prednisolone
Enzalutamide
Specified dose on specified days
Abiraterone
Specified dose on specified days
Predinsone/Prednisolone
Specified dose on specified days
Part 1: Comparator 2
Docetaxel
Specified dose on specified days
Predinsone/Prednisolone
Specified dose on specified days
Part 2: Dose Selected
BMS-986365
Specified dose on specified days
Part 2: Comparator 1
Enzalutamide or Abiraterone Acetate + Prednisone/Prednisolone
Enzalutamide
Specified dose on specified days
Abiraterone
Specified dose on specified days
Predinsone/Prednisolone
Specified dose on specified days
Part 2: Comparator 2
Docetaxel
Specified dose on specified days
Predinsone/Prednisolone
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BMS-986365
Specified dose on specified days
Enzalutamide
Specified dose on specified days
Abiraterone
Specified dose on specified days
Docetaxel
Specified dose on specified days
Predinsone/Prednisolone
Specified dose on specified days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must have current evidence of metastatic disease documented by either bone lesions on radionuclide bone scan and/or soft tissue lesions on computed tomography/magnetic resonance imaging (CT/MRI).
* Participants must be asymptomatic or mildly symptomatic from prostate cancer with score on Brief Pain Inventory - Short Form (BPI-SF) that must be \< 4.
* Participants must have had previous treatment with an androgen receptor pathway inhibitor (abiraterone, enzalutamide, apalutamide, or darolutamide).
Exclusion Criteria
* Participants must not have any brain metastasis.
* Participants must not have any liver metastasis.
* Participants with superscan on technetium-99m (Tc-99m) radionuclide bone scans.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celgene
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Alabama Research
Birmingham, Alabama, United States
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States
Los Angeles Cancer Network (LACN)
Anaheim, California, United States
Moores Cancer Center
La Jolla, California, United States
Cancer and Blood Specialty Clinic
Los Alamitos, California, United States
Local Institution - 0364
Los Angeles, California, United States
Pacific Hematology Oncology Associates
San Francisco, California, United States
San Francisco VA Health Care System
San Francisco, California, United States
Rocky Mountain Regional VA Medical Center
Aurora, Colorado, United States
Rocky Mountain Cancer Centers, LLP
Denver, Colorado, United States
Colorado Clinical Research
Lakewood, Colorado, United States
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Lakeland Regional Cancer Center
Lakeland, Florida, United States
University Cancer & Blood Center, LLC
Athens, Georgia, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
The University of Kansas Cancer Center - Westwood
Westwood, Kansas, United States
Wichita Urology Group
Wichita, Kansas, United States
Chesapeake Urology
Baltimore, Maryland, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
James M Stockman Cancer Institute
Frederick, Maryland, United States
Local Institution - 0104
Minneapolis, Minnesota, United States
Local Institution - 0049
Las Vegas, Nevada, United States
Thomas Jefferson University, Kennedy Health Alliance
Sewell, New Jersey, United States
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States
New Mexico Oncology Hematology Consultants Ltd.
Albuquerque, New Mexico, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Mineola, New York, United States
Laura and Isaac Perlmutter Cancer Center
New York, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Local Institution - 0085
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Associated Medical Professionals - Urology
Syracuse, New York, United States
Local Institution - 0056
Columbus, Ohio, United States
Providence Portland Medical Center
Portland, Oregon, United States
Providence St. Vincent Medical Center
Portland, Oregon, United States
Local Institution - 0433
Allentown, Pennsylvania, United States
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania, United States
Thomas Jefferson University - Clinical Research Institute
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Asplundh Cancer Pavilion
Willow Grove, Pennsylvania, United States
Hollings Cancer Center
Charleston, South Carolina, United States
Carolina Urologic Research Center, LLC
Myrtle Beach, South Carolina, United States
Tennessee Oncology
Nashville, Tennessee, United States
Urology Austin, PLLC
Austin, Texas, United States
Texas Oncology - Central/South Texas
Austin, Texas, United States
Local Institution - 0220
Houston, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Intermountain Medical Center
Murray, Utah, United States
University of Virginia Cancer Center
Charlottesville, Virginia, United States
Local Institution - 0023
Richmond, Virginia, United States
Local Institution - 0078
Seattle, Washington, United States
Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Hospital Británico de Buenos Aires
CABA, Buenos Aires, Argentina
Instituto Alexander Fleming
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
ABB, Buenos Aires F.D., Argentina
Hospital Italiano de Córdoba
Córdoba, Córdoba Province, Argentina
Local Institution - 0130
Río Cuarto, Córdoba Province, Argentina
Clinica Viedma S. A
Viedma, R, Argentina
Asociación de Beneficencia Hospital Sirio Libanés
Buenos Aires, , Argentina
Hospital Privado Universitario de Córdoba
Córdoba, , Argentina
GenesisCare - Campbelltown
Campbelltown, New South Wales, Australia
St Vincent's Hospital
Darlinghurst, New South Wales, Australia
Macquarie University
Macquarie University, New South Wales, Australia
Port Macquarie - Mid North Coast Cancer Institute
Port Macquarie, New South Wales, Australia
Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
Greenslopes Private Hospital - Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
Tasman Oncology Research
Southport, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia
ICON Cancer Centre - Kurralta Park
Kurralta Park, South Australia, Australia
Icon Cancer Centre Hobart
Hobart, Tasmania, Australia
Austin Health
Heidelberg, Victoria, Australia
Cabrini Hospital - Malvern
Malvern, Victoria, Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
St. John of God Murdoch Hospital
Murdoch, Western Australia, Australia
Universitätsklinikum Krems
Krems, Lower Austria, Austria
Ordensklinikum Linz GmbH Elisabethinen
Linz, Upper Austria, Austria
Uniklinikum Salzburg
Salzburg, , Austria
Medizinische Universität Wien
Vienna, , Austria
Local Institution - 0039
Vitória, Espírito Santo, Brazil
Cetus Oncologia - Unidade Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
Liga Norte Riograndense Contra o Câncer
Natal, Rio Grande do Norte, Brazil
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sírio Libanês
São Paulo, São Paulo, Brazil
A. C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
BC Cancer Kelowna
Kelowna, British Columbia, Canada
BC Cancer Vancouver
Vancouver, British Columbia, Canada
Local Institution - 0151
Halifax, Nova Scotia, Canada
Sunnybrook Research Institute
Toronto, Ontario, Canada
CIUSSS- saguenay-Lac-Saint-Jean
Chicoutimi, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus
Québec, Quebec, Canada
Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski
Rimouski, Quebec, Canada
Oncocentro Valdivia
Valdivia, Los Ríos Region, Chile
Oncocentro Apys
Viña del Mar, Región de Valparaíso, Chile
Fundacion Arturo Lopez Perez (FALP)
Santiago, Santiago Metropolitan, Chile
Bradfordhill
Santiago, Santiago Metropolitan, Chile
Second Affiliated hospital of Anhui Medical University
Hefei, Anhui, China
Local Institution - 0168
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Local Institution - 0176
Beijing, Beijing Municipality, China
Local Institution - 0237
Chongqing, Chongqing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
The First Affiliated hospital of Xiamen University
Xiamen, Fujian, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
Local Institution - 0415
Huizhou, Guangdong, China
Local Institution - 0222
Harbin, Heilongjiang, China
Local Institution - 0211
Zhengzhou, Henan, China
Local Institution - 0279
Zhengzhou, Henan, China
Local Institution - 0284
Wuhan, Hubei, China
Local Institution - 0216
Changsha, Hunan, China
Local Institution - 0217
Changsha, Hunan, China
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Local Institution - 0228
Nanjing, Jiangsu, China
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
The First affiliated hospital of Nanchang University (Xianghu campus)
Nanchang, Jiangxi, China
Local Institution - 0198
Xi'an, Shaanxi, China
Shandong Cancer Hospital
Jinan, Shandong, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Local Institution - 0300
Shanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Local Institution - 0212
Shanghai, Shanghai Municipality, China
Local Institution - 0215
Shanghai, Shanghai Municipality, China
Local Institution - 0308
Shanghai, Shanghai Municipality, China
Local Institution - 0205
Taiyuan, Shanxi, China
Sichuan Cancer hospital
Chengdu, Sichuan, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Xinjiang Medical University Cancer Hospital - Urumqi
Ürümqi, Xinjiang, China
Local Institution - 0181
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Local Institution - 0280
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Linhai, Zhejiang, China
Local Institution - 0223
Wenzhou, Zhejiang, China
Local Institution - 0011
Hořovice, Beroun, Czechia
Masarykuv onkologicky ustav
Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Hradec Králové, Czechia
Fakultni nemocnice Olomouc
Olomouc, Olomoucký kraj, Czechia
Urocentrum Praha
Prague, Praha 2, Czechia
Local Institution - 0418
Prague, Praha 4, Czechia
Fakultni nemocnice v Motole
Prague, Praha 5, Czechia
Vseobecna fakultni nemocnice v Praze
Prague, , Czechia
Herlev and Gentofte Hospital
Copenhagen, Capital Region, Denmark
Rigshospitalet
Copenhagen, Capital Region, Denmark
Aarhus Universitetshospital, Skejby
Aarhus, Central Jutland, Denmark
Aalborg Universitetshospital, Syd
Aalborg, North Denmark, Denmark
Centre Antoine-Lacassagne
Nice, Alpes-Maritimes, France
Institut de cancérologie Strasbourg Europe (ICANS)
Strasbourg, Alsace, France
Local Institution - 0432
Dijon, Côte-d'Or, France
Oncopole Claudius Regaud
Toulouse, Haute-Garonne, France
Local Institution - 0431
Saint-Grégoire, Ille-et-Vilaine, France
Institut de Cancérologie de Lorraine Alexis Vautrin
Vandœuvre-lès-Nancy, Lorraine, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, Rhône, France
Clinique Victor Hugo Le Mans
Le Mans, Sarthe, France
Gustave Roussy
Villejuif, Val-de-Marne, France
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
Clermont-Ferrand, , France
Local Institution - 0178
Paris, , France
Studienpraxis Urologie
Nürtingen, Baden-Wurttemberg, Germany
TUM Klinikum
München, Bavaria, Germany
Universitätsklinikum Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany
Universitätsklinikum Jena
Jena, Thuringia, Germany
Universitätsklinikum Bonn
Bonn, , Germany
Universitaetsklinikum Essen
Essen, , Germany
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Universitaetsklinikum Heidelberg
Heidelberg, , Germany
Marienhospital Herne
Herne, , Germany
Universitaetsklinikum Tuebingen
Tübingen, , Germany
Universitaetsklinikum Wuerzburg
Würzburg, , Germany
Local Institution - 0404
Thiruvananthapuram, Kerala, India
Local Institution - 0401
Navi Mumbai, Maharashtra, India
Local Institution - 0402
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0400
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0405
Kolkata, West Bengal, India
Cork University Hospital
Cork, , Ireland
Tallaght University Hospital
Dublin, , Ireland
Beaumont Hospital, Dublin
Dublin, , Ireland
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
Orbassano, Piedmont, Italy
Istituto Nazionale Tumori Regina Elena
Rome, Roma, Italy
Istituto Oncologico Veneto IRCCS
Padua, Veneto, Italy
Azienda USL 8 di Arezzo
Arezzo, , Italy
Local Institution - 0424
Catania, , Italy
Azienda Ospedaliero Universitaria Policlinico Riuniti di Foggia
Foggia, , Italy
Local Institution - 0425
Milan, , Italy
Istituto Nazionale Tumori IRCCS Fondazione Pascale
Napoli, , Italy
Azienda Ospedaliera Santa Maria Terni
Terni, , Italy
APSS- Presidio Ospedaliero S. Chiara
Trento, , Italy
Local Institution - 0451
Nagoya, Aichi-ken, Japan
Local Institution - 0436
Sakura, Chiba, Japan
Local Institution - 0441
Matsuyama, Ehime, Japan
Local Institution - 0444
Kamakura, Kanagawa, Japan
Local Institution - 0437
Suita, Osaka, Japan
Local Institution - 0445
Bunkyo-ku, Tokyo, Japan
Local Institution - 0447
Toyama, Toyama, Japan
Local Institution - 0450
Ube, Yamaguchi, Japan
Local Institution - 0439
Fukuoka, , Japan
Local Institution - 0434
Kashiwa, , Japan
Local Institution - 0449
Kobe, , Japan
Local Institution - 0442
Osaka, , Japan
Local Institution - 0438
Shinjuku-ku, , Japan
Pratia Poznań
Poznan, Greater Poland Voivodeship, Poland
POLIMED
Wroclaw, Lower Silesian Voivodeship, Poland
Państwowy Instytut Medyczny MSWiA
Warsaw, Masovian Voivodeship, Poland
SP ZOZ Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu
Opole, Opole Voivodeship, Poland
COPERNICUS PL, Wojewodzkie Centrum Onkologii
Gdansk, Pomeranian Voivodeship, Poland
Regional Specialised Hospital No. 4 in Bytom
Bytom, Silesian Voivodeship, Poland
Centrum Onkologii im. Prof. Franciszka Lukaszczyka
Bydgoszcz, , Poland
Pratia Onkologia Katowice
Katowice, , Poland
BRCR Global - Mayagüez
Mayagüez, , Puerto Rico
Centrul de Oncologie "Sfântul Nectarie"
Craiova, Dolj, Romania
Institutul Oncologic Cluj
Cluj-Napoca, , Romania
Spitalul Universitar C.F. Cluj-Napoca
Cluj-Napoca, , Romania
Institutul Regional de Oncologie
Iași, , Romania
Spitalul Municipal Schuller Ploiești
Ploieşti, , Romania
MILAB
Prešov, Presov, Slovakia
Local Institution - 0275
Banská Bystrica, , Slovakia
Local Institution - 0201
Bratislava, , Slovakia
Local Institution - 0200
Martin, Žilina Region, Slovakia
National Cancer Center
Goyang-si, Kyǒnggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam, Kyǒnggi-do, South Korea
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Severance Hospital, Yonsei University Health System
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Asan Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Hospital Universitario Reina Sofia
Córdoba, Andalusia, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [Barcelona], Spain
Hospital Universitari Parc Tauli
Sabadell, Barcelona [Barcelona], Spain
OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces
Barakaldo, Bizkaia, Spain
Local Institution - 0314
Santander, Cantabria, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalunya [Cataluña], Spain
Hospital Lucus Augusti
Lugo, Lugo [Lugo], Spain
Hospital General Universitario Gregorio Marañon
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario 12 de Octubre
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario La Paz
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Comunidad de, Spain
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
Complexo Hospitalario Universitario de Ourense
Ourense, Ourense [Orense], Spain
Hospital Infanta Cristina
Badajoz, , Spain
Hospital Universitario de Burgos
Burgos, , Spain
Hospital Vithas La Salud
Granada, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
Local Institution - 0327
Málaga, , Spain
Hospital Universitario Virgen Macarena
Seville, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
Hospital Universitari i Politecnic La Fe
Valencia, , Spain
Skånes Universitetssjukhus Lund
Lund, Skåne Län [se-12], Sweden
Karolinska Universitetssjukhuset Solna
Solna, Stockholms Län [se-01], Sweden
Akademiska sjukhuset
Uppsala, Uppsala Län [se-03], Sweden
Sahlgrenska Universitetssjukhuset
Gothenburg, Västra Götalands Län [se-14], Sweden
China Medical University Hospital
Taichung, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Local Institution - 0420
Taoyuan District, , Taiwan
Local Institution - 0340
Adana, , Turkey (Türkiye)
Local Institution - 0339
Ankara, , Turkey (Türkiye)
Local Institution - 0338
Ankara, , Turkey (Türkiye)
Local Institution - 0341
Ankara, , Turkey (Türkiye)
Local Institution - 0337
Istanbul, , Turkey (Türkiye)
Local Institution - 0342
Istanbul, , Turkey (Türkiye)
The Beatson West of Scotland Cancer Centre
Glasgow, Glasgow City, United Kingdom
Mount Vernon Hospital
Northwood, Hillingdon, United Kingdom
St Bartholomew's Hospital
London, London, City of, United Kingdom
Royal Marsden Hospital (Sutton)
London, Sutton, United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Role: CONTACT
First line of the email MUST contain the NCT# and Site#
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
David Mooney, Site 0330
Role: primary
Isaac Bowman, Site 0329
Role: primary
Ronald Tang, Site 0370
Role: primary
Rana McKay, Site 0015
Role: primary
Vu Phan, Site 0224
Role: primary
Ari Baron, Site 0016
Role: primary
Franklin Huang, Site 0411
Role: primary
Jessica McDermott, Site 0238
Role: primary
Manojkumar Bupathi, Site 0294
Role: primary
David Cahn, Site 0419
Role: primary
Adel Mandl, Site 0413
Role: primary
Peter Hinds, Site 0426
Role: primary
PETROS NIKOLINAKOS, Site 0077
Role: primary
David VanderWeele, Site 0048
Role: primary
Haoran Li, Site 0331
Role: primary
Timothy Richardson, Site 0060
Role: primary
Ronald Tutrone, Site 0054
Role: primary
Adel Mandl, Site 0019
Role: primary
Saro Sarkisian, Site 0344
Role: primary
Site 0104
Role: primary
Sheel Patel, Site 0429
Role: primary
Amy Tarnower, Site 0081
Role: primary
Jose Avitia, Site 0334
Role: primary
Saby George, Site 0197
Role: primary
Mary O'Keeffe, Site 0412
Role: primary
Mary O'Keeffe, Site 0069
Role: primary
Bobby Liaw, Site 0076
Role: primary
Site 0085
Role: primary
Dana Rathkopf, Site 0071
Role: primary
Christopher Pieczonka, Site 0225
Role: primary
Site 0056
Role: primary
Brendan Curti, Site 0067
Role: primary
Brendan Curti, Site 0416
Role: primary
Yu-Ning Wong, Site 0345
Role: primary
Sheel Patel, Site 0414
Role: primary
Fern Anari, Site 0057
Role: primary
Sheel Patel, Site 0349
Role: primary
Theodore Gourdin, Site 0055
Role: primary
Neal Shore, Site 0079
Role: primary
Joseph Merriman, Site 0335
Role: primary
Brian Mazzarella, Site 0114
Role: primary
Jeffrey Yorio, Site 0018
Role: primary
Site 0220
Role: primary
Andrew Hahn, Site 0042
Role: primary
David Gill, Site 0109
Role: primary
Robert Dreicer, Site 0050
Role: primary
Site 0078
Role: primary
Ian Schnadig, Site 0293
Role: primary
Kathryn Bylow, Site 0112
Role: primary
Ernesto Korbenfeld, Site 0125
Role: primary
Juan Pablo Sade, Site 0124
Role: primary
Federico Cayol, Site 0128
Role: primary
Virginia Garcia, Site 0235
Role: primary
Site 0130
Role: primary
Ruben Kowalyszyn, Site 0136
Role: primary
Hernan Cutuli, Site 0129
Role: primary
Jeremias Sierra, Site 0430
Role: primary
Felicia Roncolato, Site 0366
Role: primary
Anthony Joshua, Site 0359
Role: primary
Alison Zhang, Site 0356
Role: primary
Stephen Begbie, Site 0360
Role: primary
Gavin Marx, Site 0355
Role: primary
Kenneth O'Byrne, Site 0347
Role: primary
Andrew Hill, Site 0351
Role: primary
Thean Hsiang TAN, Site 0362
Role: primary
Christopher Hocking, Site 0358
Role: primary
Craig Gedye, Site 0352
Role: primary
Louise Nott, Site 0354
Role: primary
Andrew Weickhardt, Site 0363
Role: primary
David Pook, Site 0353
Role: primary
Shahneen Sandhu, Site 0348
Role: primary
Mark Voskoboynik, Site 0361
Role: primary
Timothy Slattery, Site 0357
Role: primary
Sonia Vallet, Site 0369
Role: primary
Ferdinand Luger, Site 0373
Role: primary
Lukas Oberhammer, Site 0367
Role: primary
Gero Kramer, Site 0368
Role: primary
Site 0039
Role: primary
Elisa Ramos, Site 0025
Role: primary
Andrea Gomes, Site 0035
Role: primary
Pedro Isaacsson Velho, Site 0026
Role: primary
Diogo Bastos, Site 0395
Role: primary
Jose Augusto Rinck Junior, Site 0031
Role: primary
Daygen Finch, Site 0304
Role: primary
Kim Chi, Site 0152
Role: primary
Site 0151
Role: primary
Daniel Khalaf, Site 0193
Role: primary
Jose Luiz Guimaraes, Site 0093
Role: primary
April Rose, Site 0149
Role: primary
Ramy Saleh, Site 0305
Role: primary
Frederic Pouliot, Site 0150
Role: primary
Samuel Nadeau, Site 0164
Role: primary
Maria Herrera, Site 0236
Role: primary
Alejandro Acevedo Gaete, Site 0127
Role: primary
Christian Caglevic, Site 0135
Role: primary
Mauricio Burotto, Site 0132
Role: primary
dexin yu, Site 0232
Role: primary
Site 0168
Role: primary
Zhisong He, Site 0192
Role: primary
Site 0176
Role: primary
Site 0237
Role: primary
Shaoxing Zhu, Site 0249
Role: primary
Jinchun Xing, Site 0213
Role: primary
Kai Yao, Site 0226
Role: primary
Keji Xie, Site 0180
Role: primary
Site 0415
Role: primary
Site 0222
Role: primary
Site 0211
Role: primary
Site 0279
Role: primary
Site 0284
Role: primary
Site 0216
Role: primary
Site 0217
Role: primary
Dong Xue, Site 0417
Role: primary
Hongqian Guo, Site 0233
Role: primary
Site 0228
Role: primary
Ming Chen, Site 0229
Role: primary
Bin Fu, Site 0219
Role: primary
Site 0198
Role: primary
Jiasheng Bian, Site 0191
Role: primary
Jitao Wu, Site 0221
Role: primary
Dingwei Ye, Site 0214
Role: primary
Site 0212
Role: primary
Site 0308
Role: primary
Site 0205
Role: primary
Hong Liao, Site 0240
Role: primary
Lu Yang, Site 0278
Role: primary
Jing Liu, Site 0283
Role: primary
Peng Chen, Site 0218
Role: primary
Site 0181
Role: primary
qi zhang, Site 0196
Role: primary
Site 0280
Role: primary
Mang Ke, Site 0281
Role: primary
Site 0223
Role: primary
Jiri Navratil, Site 0008
Role: primary
Miroslav Hodek, Site 0005
Role: primary
Bohuslav Melichar, Site 0010
Role: primary
Michaela Matouskova, Site 0009
Role: primary
Site 0418
Role: primary
Tomas Buchler, Site 0004
Role: primary
Martin Mateju, Site 0006
Role: primary
Rasmus Bisbjerg, Site 0243
Role: primary
Gedske Daugaard, Site 0098
Role: primary
Simon Buus, Site 0396
Role: primary
Mette Moe Kempel, Site 0100
Role: primary
Delphine Borchiellini, Site 0167
Role: primary
Philippe Barthelemy, Site 0169
Role: primary
Site 0432
Role: primary
Loic Mourey, Site 0307
Role: primary
Site 0431
Role: primary
Vincent Massard, Site 0177
Role: primary
Denis Maillet, Site 0166
Role: primary
Amandine Ruffier, Site 0231
Role: primary
Ronan Flippot, Site 0179
Role: primary
Hakim Mahammedi, Site 0165
Role: primary
Tilman Todenhöfer, Site 0421
Role: primary
Margitta Retz, Site 0374
Role: primary
Axel Merseburger, Site 0371
Role: primary
Marc-Oliver Grimm, Site 0380
Role: primary
Manuel Ritter, Site 0382
Role: primary
Claudia Kesch, Site 0375
Role: primary
Gunhild Von Amsberg, Site 0378
Role: primary
Stefanie Zschaebitz, Site 0379
Role: primary
Florian Roghmann, Site 0377
Role: primary
Steffen Rausch, Site 0376
Role: primary
Hubert Kuebler, Site 0372
Role: primary
Site 0404
Role: primary
Site 0401
Role: primary
Site 0402
Role: primary
Site 0400
Role: primary
Site 0405
Role: primary
Jack Gleeson, Site 0271
Role: primary
Ray Mc Dermott, Site 0272
Role: primary
Min Yuen Teo, Site 0273
Role: primary
Giuseppe Procopio, Site 0157
Role: primary
Consuelo Buttigliero, Site 0234
Role: primary
Fabio Calabro, Site 0155
Role: primary
Umberto Basso, Site 0153
Role: primary
Alketa Hamzaj, Site 0156
Role: primary
Site 0424
Role: primary
Vincenza Conteduca, Site 0409
Role: primary
Site 0425
Role: primary
Sabrina Rossetti, Site 0160
Role: primary
Annalisa Guida, Site 0159
Role: primary
Orazio Caffo, Site 0158
Role: primary
Site 0451
Role: primary
Site 0436
Role: primary
Site 0441
Role: primary
Site 0444
Role: primary
Site 0437
Role: primary
Site 0445
Role: primary
Site 0447
Role: primary
Site 0450
Role: primary
Site 0439
Role: primary
Site 0434
Role: primary
Site 0449
Role: primary
Site 0442
Role: primary
Site 0438
Role: primary
Marek Kotlarski, Site 0365
Role: primary
Krzysztof Tupikowski, Site 0346
Role: primary
Bartosz Itrych, Site 0187
Role: primary
Barbara Radecka, Site 0190
Role: primary
Joanna Wojcik-Tomaszewska, Site 0186
Role: primary
Ewa Nowakowska-Zajdel, Site 0185
Role: primary
Bogdan Zurawski, Site 0189
Role: primary
Agata Kachel-Flis, Site 0336
Role: primary
Maryangely Moreno Campa, Site 0117
Role: primary
Michael Schenker, Site 0139
Role: primary
Tudor Ciuleanu, Site 0145
Role: primary
Anca Mihailov, Site 0144
Role: primary
Teodora Alexa-Stratulat, Site 0141
Role: primary
Nita Amedeia, Site 0142
Role: primary
Ivan Mincik, Site 0381
Role: primary
Site 0275
Role: primary
Site 0201
Role: primary
Site 0200
Role: primary
Jae Young Joung, Site 0389
Role: primary
Sung-Kyu Hong, Site 0386
Role: primary
Cheol Kwak, Site 0385
Role: primary
Young Deuk Choi, Site 0387
Role: primary
Jae Lyun Lee, Site 0388
Role: primary
Se Hoon Park, Site 0384
Role: primary
MARIA JOSE MENDEZ VIDAL, Site 0312
Role: primary
Joaquin Mateo Valderrama, Site 0310
Role: primary
Enrique Gallardo Diaz, Site 0311
Role: primary
Ricardo Fernández Rodríguez, Site 0325
Role: primary
Site 0314
Role: primary
Jose Pablo Maroto Rey, Site 0315
Role: primary
Sergio Vazquez Estevez, Site 0319
Role: primary
Jose Arranz Arija, Site 0321
Role: primary
Teresa Alonso Gordoa, Site 0316
Role: primary
Daniel Castellano Gauna, Site 0317
Role: primary
Alvaro Pinto Marin, Site 0323
Role: primary
Aranzazu Gonzalez del Alba, Site 0326
Role: primary
Nuria Lainez Milagro, Site 0406
Role: primary
Ovidio Fernandez Calvo, Site 0407
Role: primary
Marta Gonzalez Cordero, Site 0320
Role: primary
GUILLERMO CRESPO HERRERO, Site 0328
Role: primary
Pedro Sanchez Rovira, Site 0318
Role: primary
Javier Puente Vazquez, Site 0309
Role: primary
Site 0327
Role: primary
ALBERTO SANCHEZ CAMACHO MEJIAS, Site 0322
Role: primary
Begona Perez Valderrama, Site 0313
Role: primary
Regina Girones Sarrio, Site 0324
Role: primary
Olof Staahl, Site 0099
Role: primary
Enrique Castellanos, Site 0408
Role: primary
INGRIDA VERBIENE, Site 0097
Role: primary
Jon Kindblom, Site 0095
Role: primary
Hsi-Chin Wu, Site 0398
Role: primary
Yeong-Shiau Pu, Site 0399
Role: primary
Tzu-Chun Wei, Site 0397
Role: primary
Site 0420
Role: primary
Site 0340
Role: primary
Site 0339
Role: primary
Site 0338
Role: primary
Site 0341
Role: primary
Site 0337
Role: primary
Site 0342
Role: primary
Robert Jones, Site 0393
Role: primary
anand sharma, Site 0383
Role: primary
Kenrick Ng, Site 0266
Role: primary
Alison Reid, Site 0391
Role: primary
Andrew Hudson, Site 0248
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Chi KN, McKay RR, Sandhu S, Arranz JA, Barthelemy P, Hadaschik B, Matsubara N, Shore ND, Ye D, Cascella T, Irincheeva I, Kreiser S, Thiery-Vuillemin A, Rathkopf DE. rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator's choice in patients with mCRPC. Future Oncol. 2025 Jun;21(14):1771-1777. doi: 10.1080/14796694.2025.2502318. Epub 2025 Jun 2.
Related Links
Access external resources that provide additional context or updates about the study.
BMS Clinical Trial Information
BMS Clinical Trial Patient Recruiting
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-517422-25
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1311-0532
Identifier Type: OTHER
Identifier Source: secondary_id
CA071-1000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.